IVERIC bio, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Collaboration revenue
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Interest income, net
Gain on extinguishment of Royalty Purchase Liability
Gain on sale of IC100 & IC200
Other income (expense), net
Loss before income tax benefit
Income tax benefit
Net loss
Net loss per common share:
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted average common shares outstanding:
Basic (in shares)
Diluted (in shares)

Comments